PDCD1 and melanoma: SubMap analysis indicated that patients in the immune‐activated subtype shared a similar gene expression profile to melanoma patients who were responsive to anti‐PD‐1 immunotherapy (Bonferroni‐corrected P = 0.0079, Fig. 3C).